Belvedere Trading’s Immunogen Inc IMGN Stock Holding History

Belvedere Trading’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$59.3K	–	1093
2023 Q4	$59.3K	Buy	+2,000	New	+$39.8K	﹤0.01%	545
2023 Q3	–	Sell	-24,400	Closed	-$460K	–	1052
2023 Q2	$460K	Buy	24,400 +10,500	+76%	+$124K	﹤0.01%	152
2023 Q1	$53.4K	Buy	+13,900	New	+$59.2K	﹤0.01%	576

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Belvedere Trading's IMGN Position: Q1 2024 in Review

Belvedere Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 12,662 shares — an estimated $375K sold.

Belvedere Trading first reported a position in IMGN in Q1 2023 and held it in 4 quarters. The position peaked at $375K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Belvedere Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Belvedere Trading sold 12,662 Immunogen Inc shares in Q1 2024, an estimated $375K.
Belvedere Trading first reported a position in Immunogen Inc in Q1 2023 and held it in 4 quarters.
Belvedere Trading's Immunogen Inc position peaked at $375K in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Belvedere Trading's 13F filing for Q1 2024, filed 9 May 2024.